Anti-drug monoclonal antibodies antagoni
Anti-drug monoclonal antibodies antagonize toxic effect more than anti-tumor activity of doxorubicin
✍
A. Balsari; S. Ménard; M. I. Colnaghi; M. Ghione
📂
Article
📅
1991
🏛
John Wiley and Sons
🌐
French
⚖ 376 KB